| TOVX Stock | | | USD 1.28 0.02 1.59% |
Theriva Biologics financial indicator trend analysis is much more than just breaking down Theriva Biologics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Theriva Biologics is a good investment. Please check the relationship between Theriva Biologics Gross Profit and its Minority Interest accounts. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Theriva Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in real.
For more information on how to buy Theriva Stock please use our
How to Invest in Theriva Biologics guide.
Gross Profit vs Minority Interest
Gross Profit vs Minority Interest Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Theriva Biologics Gross Profit account and
Minority Interest. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Theriva Biologics' Gross Profit and Minority Interest is -0.25. Overlapping area represents the amount of variation of Gross Profit that can explain the historical movement of Minority Interest in the same time period over historical financial statements of Theriva Biologics, assuming nothing else is changed. The correlation between historical values of Theriva Biologics' Gross Profit and Minority Interest is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit of Theriva Biologics are associated (or correlated) with its Minority Interest. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Minority Interest has no effect on the direction of Gross Profit i.e., Theriva Biologics' Gross Profit and Minority Interest go up and down completely randomly.
Correlation Coefficient | -0.25 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Theriva Biologics minus its cost of goods sold. It is profit before Theriva Biologics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.
Minority Interest
Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of Theriva Biologics whose combined shares represent less than 50% of the total outstanding shares issued by Theriva Biologics have a minority interest in Theriva Biologics.
Most indicators from Theriva Biologics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Theriva Biologics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Theriva Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in real.
For more information on how to buy Theriva Stock please use our
How to Invest in Theriva Biologics guide.At this time, Theriva Biologics'
Enterprise Value Over EBITDA is fairly stable compared to the past year.
Enterprise Value Multiple is likely to rise to 0.75 in 2024, whereas
Selling General Administrative is likely to drop slightly above 7.1
M in 2024.
Theriva Biologics fundamental ratios Correlations
Click cells to compare fundamentals
Theriva Biologics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Theriva Biologics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Theriva Stock Analysis
When running Theriva Biologics' price analysis, check to
measure Theriva Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theriva Biologics is operating at the current time. Most of Theriva Biologics' value examination focuses on studying past and present price action to
predict the probability of Theriva Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theriva Biologics' price. Additionally, you may evaluate how the addition of Theriva Biologics to your portfolios can decrease your overall portfolio volatility.